0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-2545.50%PremiumJan 17, 2025Expiry Date4.81Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.04Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Viracta Therapeutics Stock Discussion
1 min ago
Viracta Therapeutics Announces Closure of Naval-1 Clinical Trial and Exploration of Strategic Alternatives
Viracta Therapeutics Inc - Closure of Trial Not Due to New Safety Finding
Viracta Therapeutics Inc - Potential Alternatives Include Merger, Licensing Agreement, Sale
No comment yet